Literature DB >> 11594106

Laparoscopic biliopancreatic diversion for the treatment of morbid obesity: initial experience.

D Paiva1, L Bernardes, L Suretti.   

Abstract

BACKGROUND: Open biliopancreatic diversion (BPD) is a proven effective operation for morbid obesity. We developed a technique which permits BPD to be performed laparoscopically.
METHODS: 10 patients were submitted to BPD by laparoscopy in July and August 2000 for the treatment of morbid obesity. All patients were morbidly obese (BMI 40-55).
RESULTS: All operations were performed by laparoscopy with no need to convert to laparotomy. No complications related to surgery were observed.
CONCLUSION: The technique, with an acceptable level of complexity, can be safely executed by laparoscopy as described by Scopinaro.

Entities:  

Mesh:

Year:  2001        PMID: 11594106     DOI: 10.1381/09608920160556832

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  4 in total

1.  Laparoscopic versus open biliopancreatic diversion: a prospective comparative study.

Authors:  Valerio Ceriani; Tiziana Lodi; Andrea Porta; Paolo Gaffuri; Edoardo Faleschini; Oscar Roncaglia; Chiara Osio; Massimiliano Coladonato; Ahmed Elnabil-Mortada
Journal:  Obes Surg       Date:  2010-10       Impact factor: 4.129

Review 2.  Metabolic surgery-principles and current concepts.

Authors:  M Gass; C Beglinger; R Peterli
Journal:  Langenbecks Arch Surg       Date:  2011-08-26       Impact factor: 3.445

3.  Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  S Sauerland; L Angrisani; M Belachew; J M Chevallier; F Favretti; N Finer; A Fingerhut; M Garcia Caballero; J A Guisado Macias; R Mittermair; M Morino; S Msika; F Rubino; R Tacchino; R Weiner; E A M Neugebauer
Journal:  Surg Endosc       Date:  2004-12-02       Impact factor: 4.584

Review 4.  Biliopancreatic diversion in the surgical treatment of morbid obesity.

Authors:  Robrecht H G G Van Hee
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.